Biosimilars-On-Biologics Market Report

China Biosimilars-On-Biologics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：154
  • REPORT CODE：GMM1786955
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Biosimilars-On-Biologics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Biogen idec Inc

    • Novartis

    • Biocon

    • Celltrion

    • LG Life Sciences

    • Synthon Pharmaceuticals, Inc

    • Merck Serono

    • Hospira

    By Type:

    • Insulin

    • Peptide

    • Erythropoietin

    • Human growth hormone

    • Granulocyte-Colony Stimulating Factor

    • Monoclonal antibodies

    • Interferon

    By Application:

    • Growth hormone deficiencies

    • Blood disorders

    • Oncology diseases

    • Chronic and autoimmune diseases

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Biosimilars-On-Biologics Market Overview 2018-2029

    • 1.1 China Biosimilars-On-Biologics Industry Development Overview

    • 1.2 China Biosimilars-On-Biologics Industry Development History

    • 1.3 China Biosimilars-On-Biologics Industry Market Size (2018-2029)

    • 1.4 China Biosimilars-On-Biologics Market Analysis by Type from Production Side

      • 1.4.1 China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Insulin (2018-2029)

      • 1.4.2 China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Peptide (2018-2029)

      • 1.4.3 China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)

      • 1.4.4 China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Human growth hormone (2018-2029)

      • 1.4.5 China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Granulocyte-Colony Stimulating Factor (2018-2029)

      • 1.4.6 China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Monoclonal antibodies (2018-2029)

      • 1.4.7 China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Interferon (2018-2029)

    • 1.5 China Biosimilars-On-Biologics Market Analysis by Application from Consumption End

      • 1.5.1 China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Growth hormone deficiencies (2018-2029)

      • 1.5.2 China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Blood disorders (2018-2029)

      • 1.5.3 China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Oncology diseases (2018-2029)

      • 1.5.4 China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Chronic and autoimmune diseases (2018-2029)

    • 1.6 China Biosimilars-On-Biologics Market Analysis by Region

      • 1.6.1 North China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Biosimilars-On-Biologics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Biosimilars-On-Biologics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Biosimilars-On-Biologics Market Status and Competition Analysis in 2023

      • 2.2.3 China Biosimilars-On-Biologics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Biosimilars-On-Biologics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Biosimilars-On-Biologics Industry Development

    Chapter 3 Biosimilars-On-BiologicsIndustry Chain Analysis

    • 3.1 Biosimilars-On-Biologics Industry Chain

    • 3.2 Biosimilars-On-Biologics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Biosimilars-On-Biologics Market

    • 3.3 Biosimilars-On-Biologics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Biosimilars-On-Biologics Market

    Chapter 4 China Biosimilars-On-Biologics Market, by Type

    • 4.1 China Biosimilars-On-Biologics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Biosimilars-On-Biologics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Biosimilars-On-Biologics Production Volume and Growth Rate, by Type

      • 4.5.1 China Biosimilars-On-Biologics Production Volume and Growth Rate of Insulin

      • 4.5.2 China Biosimilars-On-Biologics Production Volume and Growth Rate of Peptide

      • 4.5.3 China Biosimilars-On-Biologics Production Volume and Growth Rate of Erythropoietin

      • 4.5.4 China Biosimilars-On-Biologics Production Volume and Growth Rate of Human growth hormone

      • 4.5.5 China Biosimilars-On-Biologics Production Volume and Growth Rate of Granulocyte-Colony Stimulating Factor

      • 4.5.6 China Biosimilars-On-Biologics Production Volume and Growth Rate of Monoclonal antibodies

      • 4.5.7 China Biosimilars-On-Biologics Production Volume and Growth Rate of Interferon

    Chapter 5 China Biosimilars-On-Biologics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Biosimilars-On-Biologics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Biosimilars-On-Biologics Market Size and Growth Rate, by Application

      • 5.5.1 China Biosimilars-On-Biologics Market Size and Growth Rate of Growth hormone deficiencies

      • 5.5.2 China Biosimilars-On-Biologics Market Size and Growth Rate of Blood disorders

      • 5.5.3 China Biosimilars-On-Biologics Market Size and Growth Rate of Oncology diseases

      • 5.5.4 China Biosimilars-On-Biologics Market Size and Growth Rate of Chronic and autoimmune diseases

    Chapter 6 China Biosimilars-On-Biologics Market, by Region

    • 6.1 China Biosimilars-On-Biologics Production Volume and Production Value, by Region

    • 6.2 China Biosimilars-On-Biologics Sales Volume and Sales Value, by Region

    Chapter 7 North China Biosimilars-On-Biologics Market Analysis

    • 7.1 North China Biosimilars-On-Biologics Market, by Type

    • 7.2 North China Biosimilars-On-Biologics Market, by Application

    Chapter 8 Central China Biosimilars-On-Biologics Market Analysis

    • 8.1 Central China Biosimilars-On-Biologics Market, by Type

    • 8.2 Central China Biosimilars-On-Biologics Market, by Application

    Chapter 9 South China Biosimilars-On-Biologics Market Analysis

    • 9.1 South China Biosimilars-On-Biologics Market, by Type

    • 9.2 South China Biosimilars-On-Biologics Market, by Application

    Chapter 10 East China Biosimilars-On-Biologics Market Analysis

    • 10.1 East China Biosimilars-On-Biologics Market, by Type

    • 10.2 East China Biosimilars-On-Biologics Market, by Application

    Chapter 11 Northeast China Biosimilars-On-Biologics Market Analysis

    • 11.1 Northeast China Biosimilars-On-Biologics Market, by Type

    • 11.2 Northeast China Biosimilars-On-Biologics Market, by Application

    Chapter 12 Southwest China Biosimilars-On-Biologics Market Analysis

    • 12.1 Southwest China Biosimilars-On-Biologics Market, by Type

    • 12.2 Southwest China Biosimilars-On-Biologics Market, by Application

    Chapter 13 Northwest China Biosimilars-On-Biologics Market Analysis

    • 13.1 Northwest China Biosimilars-On-Biologics Market, by Type

    • 13.2 Northwest China Biosimilars-On-Biologics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Biogen idec Inc

        • 14.1.1 Biogen idec Inc Company Profile

        • 14.1.2 Biogen idec Inc Biosimilars-On-Biologics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Novartis

        • 14.2.1 Novartis Company Profile

        • 14.2.2 Novartis Biosimilars-On-Biologics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Biocon

        • 14.3.1 Biocon Company Profile

        • 14.3.2 Biocon Biosimilars-On-Biologics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Celltrion

        • 14.4.1 Celltrion Company Profile

        • 14.4.2 Celltrion Biosimilars-On-Biologics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 LG Life Sciences

        • 14.5.1 LG Life Sciences Company Profile

        • 14.5.2 LG Life Sciences Biosimilars-On-Biologics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Synthon Pharmaceuticals, Inc

        • 14.6.1 Synthon Pharmaceuticals, Inc Company Profile

        • 14.6.2 Synthon Pharmaceuticals, Inc Biosimilars-On-Biologics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck Serono

        • 14.7.1 Merck Serono Company Profile

        • 14.7.2 Merck Serono Biosimilars-On-Biologics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Hospira

        • 14.8.1 Hospira Company Profile

        • 14.8.2 Hospira Biosimilars-On-Biologics Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Biosimilars-On-Biologics Industry Research Conclusions

    • 15.2 Biosimilars-On-Biologics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Biosimilars-On-Biologics Industry Market Size (2018-2029)

    • Figure China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Insulin (2018-2029)

    • Figure China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Peptide (2018-2029)

    • Figure China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)

    • Figure China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Human growth hormone (2018-2029)

    • Figure China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Granulocyte-Colony Stimulating Factor (2018-2029)

    • Figure China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Monoclonal antibodies (2018-2029)

    • Figure China Biosimilars-On-Biologics Production Volume, Production Value and Growth Rate of Interferon (2018-2029)

    • Figure China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Growth hormone deficiencies (2018-2029)

    • Figure China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Blood disorders (2018-2029)

    • Figure China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Oncology diseases (2018-2029)

    • Figure China Biosimilars-On-Biologics Sales Volume, Sales Value and Growth Rate of Chronic and autoimmune diseases (2018-2029)

    • Figure North China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    • Figure Central China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    • Figure South China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    • Figure East China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Biosimilars-On-Biologics Market Size and Growth Rate from 2018-2029

    • Figure Biosimilars-On-Biologics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Biosimilars-On-Biologics Market Share by Type in 2018

    • Figure China Biosimilars-On-Biologics Market Share by Type in 2023

    • Figure China Biosimilars-On-Biologics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume and Growth Rate of Insulin (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume and Growth Rate of Peptide (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume and Growth Rate of Erythropoietin (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume and Growth Rate of Human growth hormone (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume and Growth Rate of Monoclonal antibodies (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume and Growth Rate of Interferon (2018-2023)

    • Figure China Biosimilars-On-Biologics Market Share by Application in 2018

    • Figure China Biosimilars-On-Biologics Market Share by Application in 2023

    • Figure China Biosimilars-On-Biologics Total Market Size and Growth Rate from Consumption End

    • Figure China Biosimilars-On-Biologics Market Size and Growth Rate of Growth hormone deficiencies (2018-2023)

    • Figure China Biosimilars-On-Biologics Market Size and Growth Rate of Blood disorders (2018-2023)

    • Figure China Biosimilars-On-Biologics Market Size and Growth Rate of Oncology diseases (2018-2023)

    • Figure China Biosimilars-On-Biologics Market Size and Growth Rate of Chronic and autoimmune diseases (2018-2023)

    • Table China Biosimilars-On-Biologics Production Volume by Region (2018-2023)

    • Table China Biosimilars-On-Biologics Production Volume Share by Region (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Volume Share by Region (2018-2023)

    • Table China Biosimilars-On-Biologics Production Value by Region (2018-2023)

    • Table China Biosimilars-On-Biologics Production Value Share by Region (2018-2023)

    • Figure China Biosimilars-On-Biologics Production Value Share by Region (2018-2023)

    • Table China Biosimilars-On-Biologics Sales Volume by Region (2018-2023)

    • Table China Biosimilars-On-Biologics Sales Volume Share by Region (2018-2023)

    • Figure China Biosimilars-On-Biologics Sales Volume Share by Region (2018-2023)

    • Table China Biosimilars-On-Biologics Sales Value by Region (2018-2023)

    • Table China Biosimilars-On-Biologics Sales Value Share by Region (2018-2023)

    • Figure China Biosimilars-On-Biologics Sales Value Share by Region (2018-2023)

    • Table North China Biosimilars-On-Biologics Production Volume by Type (2018-2023)

    • Table North China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Figure North China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Table North China Biosimilars-On-Biologics Sales Volume by Application (2018-2023)

    • Table North China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Figure North China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Table Central China Biosimilars-On-Biologics Production Volume by Type (2018-2023)

    • Table Central China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Figure Central China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Table Central China Biosimilars-On-Biologics Sales Volume by Application (2018-2023)

    • Table Central China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Figure Central China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Table South China Biosimilars-On-Biologics Production Volume by Type (2018-2023)

    • Table South China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Figure South China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Table South China Biosimilars-On-Biologics Sales Volume by Application (2018-2023)

    • Table South China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Figure South China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Table East China Biosimilars-On-Biologics Production Volume by Type (2018-2023)

    • Table East China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Figure East China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Table East China Biosimilars-On-Biologics Sales Volume by Application (2018-2023)

    • Table East China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Figure East China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Biosimilars-On-Biologics Production Volume by Type (2018-2023)

    • Table Northeast China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Table Northeast China Biosimilars-On-Biologics Sales Volume by Application (2018-2023)

    • Table Northeast China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Biosimilars-On-Biologics Production Volume by Type (2018-2023)

    • Table Southwest China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Table Southwest China Biosimilars-On-Biologics Sales Volume by Application (2018-2023)

    • Table Southwest China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Biosimilars-On-Biologics Production Volume by Type (2018-2023)

    • Table Northwest China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Biosimilars-On-Biologics Production Volume Share by Type (2018-2023)

    • Table Northwest China Biosimilars-On-Biologics Sales Volume by Application (2018-2023)

    • Table Northwest China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Biosimilars-On-Biologics Sales Volume Share by Application (2018-2023)

    • Table Biogen idec Inc Company Profile

    • Table Biogen idec Inc Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)

    • Table Celltrion Company Profile

    • Table Celltrion Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)

    • Table LG Life Sciences Company Profile

    • Table LG Life Sciences Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)

    • Table Synthon Pharmaceuticals, Inc Company Profile

    • Table Synthon Pharmaceuticals, Inc Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)

    • Table Merck Serono Company Profile

    • Table Merck Serono Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)

    • Table Hospira Company Profile

    • Table Hospira Biosimilars-On-Biologics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US